Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Russia Mandatory state licensing of production and circulation on the way…
  • Canada Date set for new rules on health warnings…
  • Ukraine Duty Free tobacco sales could be stopped…
  • Lithuania Health committee approves heated tobacco flavours ban…
  • India Tobacco warnings rule could force streaming services to quit India…
  • Malaysia Birthdate-based tobacco ban back on Parliament agenda…
  • Finland Retailers urged not to sell nicotine pouches pending new regulations…
  • Czech Republic Heated tobacco flavour ban signed into law…
  • South Africa Committee shows mixed reactions to tobacco control bill…
  • Europe EC answers MEP question over possible conflict of interest…
  • Ukraine Resolution published on restricting minors’ access to heated tobacco websi ...
  • Russia State Duma passes bill to license production and distribution…
View all
News analysis

IQOS reaction: ‘Approval works for PMI, but what about the little guy?’

Written by || 2nd May 2019 || News analysis | Heated tobacco | IQOS | North America United States

There have been mixed reactions from within the industry to the FDA decision to allow PMI’s heated-tobacco device IQOS and its associated consumables onto the US market ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

FDA gives the green light for IQOS roll-out onto the US market
PMI: ‘no ceiling in sight for heated tobacco products’
PMTA and MRTP: navigating the path to FDA approval for reduced-risk products
© 2023
TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence,
does not accept any liability or responsibility for information or views published.